Core Insights - He Eye Hospital has been awarded the "2025 Annual Listed Company ESG Value Transmission Award" and the "2025 Annual Listed Company AI Frontier Innovation Award" for its continuous efforts in ESG value transmission and pioneering applications of artificial intelligence in ophthalmology [1] Group 1: ESG Commitment - He Eye Hospital has been dedicated to the field of eye health for 30 years, focusing on prevention and treatment, and providing specialized ophthalmic diagnosis and vision care services [2] - As of June 30, 2025, the company operates 127 ophthalmic service institutions across key regions in China, aligning with the "Healthy China" strategy and the United Nations Sustainable Development Goals [2] - The company has trained over 50,000 grassroots doctors and eye health management personnel, contributing to a people-centered eye health system [2] Group 2: AI Innovations - The recognition of the AI Frontier Innovation Award highlights He Eye Hospital's technological innovation and clinical implementation capabilities in smart healthcare [3] - The company has integrated AI technology into its operations, enhancing efficiency in data collection and analysis, and optimizing clinical services through an AI imaging cloud platform [3] - The "He Diabetes Manager" utilizes AI deep learning algorithms for real-time blood sugar monitoring, aiming for precise diabetes management and eye disease prevention [3] Group 3: Refractive Surgery Advancements - In the field of refractive surgery, AI technology is applied to create personalized models for corneal aberration data, shifting surgical decision-making from experience-based to data-driven [4] - AI technology aids in preoperative risk assessment by intelligently analyzing eye images, enhancing surgical safety and control [4] - The integration of AI with visualization systems allows for better patient experience by presenting postoperative outcomes and optimizing surgical processes [4]
何氏眼科荣获AI创新与ESG实践两项行业奖